Sign in to view content

PULSAR Extension: Clinical Improvements Sustained Over 156 Weeks With Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration

David T.W. Wong, MD, FRCS(C), FASRS

Video
Published 2025

Related

Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
Annual Meeting Talks
2020
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Relationship Between Number of Intermediate-Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the DERBY, OAKS, and FILLY Trials
Eleonora Lad, MD, PhD
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more